Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Equity (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Return on Equity for 12 consecutive years, with 1.53% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 99.0% year-over-year to 1.53%, compared with a TTM value of 1.53% through Sep 2025, down 99.0%, and an annual FY2024 reading of 0.33%, up 26.0% over the prior year.
  • Return on Equity was 1.53% for Q3 2025 at Tandem Diabetes Care, down from 1.42% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.06% in Q3 2021 and bottomed at 1.53% in Q3 2025.
  • Average Return on Equity over 5 years is 0.46%, with a median of 0.51% recorded in 2024.
  • The sharpest move saw Return on Equity surged 33bps in 2024, then crashed -99bps in 2025.
  • Year by year, Return on Equity stood at 0.04% in 2021, then plummeted by -681bps to 0.22% in 2022, then plummeted by -223bps to 0.71% in 2023, then skyrocketed by 46bps to 0.38% in 2024, then tumbled by -298bps to 1.53% in 2025.
  • Business Quant data shows Return on Equity for TNDM at 1.53% in Q3 2025, 1.42% in Q2 2025, and 0.88% in Q1 2025.